Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus

Healthcare stocks are down about 6% year to date in 2026, making the sector the worst performer among all 11 S&P 500 sectors. The article signals sustained underperformance and weak investor appetite for the group, though it provides no company-specific catalyst or new policy development. Impact is more sentiment-driven than event-driven.

Analysis

Healthcare stocks are down about 6% year to date in 2026, making the sector the worst performer among all 11 S&P 500 sectors. The article signals sustained underperformance and weak investor appetite for the group, though it provides no company-specific catalyst or new policy development. Impact is more sentiment-driven than event-driven.